BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Reata Pharmaceuticals, Inc. Release: First-In-Man Study of RTA 402 Yields Promising Results in Patients with Advanced Cancers

  June 2, 2008

   · 

  1 min read
• Drug Development

  Nektar Therapeutics Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)

  June 2, 2008

   · 

  6 min read
• Drug Development

  Medarex, Inc. Release: Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  5 min read
• Moffitt Cancer Center Release: Data Presented at American Society of Clinical Oncology Finds REVLIMID as a Monotherapy is Effective and Well-Tolerated for Previously Treated Multiple Myeloma Patients

  June 2, 2008

   · 

  1 min read
• Drug Development

  Clarification on Press Release Issued Earlier Today: Targeted Genetics Corporation Confirms Positive, Interim Phase 1/2 Study Findings; Trial Demonstrates Safety and Preliminary Efficacy and Supports Further Clinical Development of tgAAC94, Data Presented

  June 2, 2008

   · 

  3 min read
• Drug Development

  Radiation Therapy Oncology Group Study: Adding Cetuximab to Chemotherapy and Radiotherapy Leads to Improved Outcome for Lung Cancer Patients

  June 2, 2008

   · 

  1 min read
• Drug Development

  Poniard Pharmaceuticals, Inc. Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer - Poster Presented at American Society of Clinical Oncology Annual

  June 2, 2008

   · 

  5 min read
• Drug Development

  YM BioSciences Reports Nimotuzumab NSCLC Clinical Data At American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  5 min read
• Business

  Alnylam Pharmaceuticals Announces Close of Investment and Expanded Agreement Related to the Tekmira Pharmaceuticals Corporation-Protiva Biotherapeutics Business Combination

  June 2, 2008

   · 

  1 min read
• BioMidwest

  The International Myeloma Foundation Says New Studies Show Longer Survival for Myeloma Patients and Improved Response to Treatments

  June 2, 2008

   · 

  1 min read